Articles
Clinical Investigation nature publishing groupBackground: The 22q11.2 deletion syndrome (22q11.2DS) is a congenital multisystem anomaly characterized by typical facial features, palatal anomalies, congenital heart defects, hypocalcemia, immunodeficiency, and cognitive and neuropsychiatric symptoms. The aim of our study was to investigate T-and B-lymphocyte characteristics associated with 22q11.2DS. Methods: Seventy-five individuals with 22q11.2DS were tested for T and B lymphocytes by examination of T-cell receptor rearrangement excision circles (TRECs) and B-cell κ-deleting recombination excision circles (KRECs), respectively. results: The 22q11.2DS individuals displayed low levels of TRECs, while exhibiting normal levels of KRECs. There was a significant positive correlation between TREC and KREC in the 22q11.2DS group, but not in controls. Both TREC and KREC levels showed a significant decrease with age and only TREC was low in 22q11.2DS individuals with recurrent infections. No difference in TREC levels was found between 22q11.2DS individuals who underwent heart surgery (with or without thymectomy) and those who did not. conclusion: T-cell immunodeficiency in 22q11.2DS includes low TREC levels, which may contribute to recurrent infections in individuals with this syndrome. A correlation between T-and B-cell abnormalities in 22q11.2DS was identified. The B-cell abnormalities could account for part of the immunological deficiency seen in 22q11.2DS. t he 22q11.2 deletion syndrome (22q11.2DS) is a multisystem congenital disorder caused by a microdeletion of one of the two copies of chromosome 22q11.2 (1-3). It occurs in ~1/4,000 live births and is characterized by typical facial features, palatal anomalies, congenital heart defects, hypocalcemia, immune deficits, intellectual disability and neuropsychiatric symptoms (4). The immunodeficiency in 22q11.2DS, which varies in its severity, appears in 65-77% of patients and leads to increased susceptibility to recurrent infections and higher rate of autoimmune disorders (5). While the major immunodeficiency in 22q11.2DS involves the cellular arm of the immune system (6), some humoral abnormalities have been described (7,8). The majority of 22q11.2DS individuals exhibit mild-to-moderate reductions in the number of T cells and only a mild deficit in T-cell function (6-9). The T-cell immunodeficiency is due to abnormal thymic migration in most cases and not necessarily due to a full thymic aplasia. Thus, residual microscopic nests of thymic epithelial cells account for some ability to produce T cells (8). Nevertheless, in ~1% of patients, there is a complete absence of thymus ("complete" DiGeorge syndrome), causing severe T-cell immunodeficiency, mimicking severe combined immunodeficiency (SCID) phenotype (5,10), and should be diagnosed early in life. These patients might benefit from hematopoietic stem cell transplantation (HSCT). In the absence of a functional thymus, it appears that the immune reconstitution by HSCT is achieved through peripheral expansion of...